You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

crizotinib

( kriz-OH-ti-nib )
Funding:
Exceptional Access Program
  • crizotinib - ALK-positive advanced NSCLC, according to specific criteria
Other Name(s): Xalkori® (Pfizer)
Appearance: capsule available in various strengths

Patient Info Sheet

Sep 2017

What it is used for

For treating specific types of non-small cell lung cancer that cannot be removed by surgery or has spread to other parts of the body.  



You might also be interested in